Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TCF12
|
ENSG00000140262.13 | transcription factor 12 |
ASCL2
|
ENSG00000183734.4 | achaete-scute family bHLH transcription factor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ASCL2 | hg19_v2_chr11_-_2292182_2292212 | 0.19 | 2.9e-01 | Click! |
TCF12 | hg19_v2_chr15_+_57211318_57211355 | -0.18 | 3.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_39258461 | 8.43 |
ENST00000440582.1
|
KRTAP4-16P
|
keratin associated protein 4-16, pseudogene |
chr22_+_22730353 | 8.29 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr16_+_23847267 | 8.27 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
chr1_+_27668505 | 7.01 |
ENST00000318074.5
|
SYTL1
|
synaptotagmin-like 1 |
chr16_+_23847339 | 7.01 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr5_-_176936844 | 6.66 |
ENST00000510380.1
ENST00000510898.1 ENST00000357198.4 |
DOK3
|
docking protein 3 |
chr22_-_37882395 | 6.40 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr22_+_22707260 | 6.38 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
chr16_+_23847355 | 6.10 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
chr5_-_176936817 | 5.64 |
ENST00000502885.1
ENST00000506493.1 |
DOK3
|
docking protein 3 |
chr2_+_90273679 | 5.60 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr21_-_46330545 | 5.46 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr11_+_128634589 | 5.45 |
ENST00000281428.8
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr14_-_107114267 | 5.41 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr17_+_34538310 | 5.41 |
ENST00000444414.1
ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1 |
chr14_-_106781017 | 5.37 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chr15_+_89182178 | 5.31 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr17_-_39296739 | 5.28 |
ENST00000345847.4
|
KRTAP4-6
|
keratin associated protein 4-6 |
chr2_-_89278535 | 5.26 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr16_+_32077386 | 5.22 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr2_-_89327228 | 5.17 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr14_-_106791536 | 5.14 |
ENST00000390613.2
|
IGHV3-30
|
immunoglobulin heavy variable 3-30 |
chr15_+_89182156 | 5.06 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr15_+_89181974 | 5.03 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr2_-_90538397 | 5.00 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
chr22_+_23241661 | 4.95 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr22_+_23029188 | 4.89 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr2_+_90259593 | 4.85 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr16_-_89043377 | 4.76 |
ENST00000436887.2
ENST00000448839.1 ENST00000360302.2 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr14_-_106692191 | 4.67 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr14_-_107211459 | 4.65 |
ENST00000390636.2
|
IGHV3-73
|
immunoglobulin heavy variable 3-73 |
chr14_-_106878083 | 4.63 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr6_-_24911195 | 4.61 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
chr2_+_87565634 | 4.52 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr14_-_106322288 | 4.49 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr17_-_39274606 | 4.48 |
ENST00000391413.2
|
KRTAP4-11
|
keratin associated protein 4-11 |
chr20_+_44637526 | 4.45 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr17_-_39280419 | 4.32 |
ENST00000394014.1
|
KRTAP4-12
|
keratin associated protein 4-12 |
chr20_+_37434329 | 4.20 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
chr17_+_34431212 | 4.19 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr2_+_90211643 | 4.15 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr17_+_34639793 | 4.13 |
ENST00000394465.2
ENST00000394463.2 ENST00000378342.4 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
chr20_+_62367989 | 4.10 |
ENST00000309546.3
|
LIME1
|
Lck interacting transmembrane adaptor 1 |
chr5_-_94620239 | 3.95 |
ENST00000515393.1
|
MCTP1
|
multiple C2 domains, transmembrane 1 |
chr2_-_235405168 | 3.93 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr2_-_158345462 | 3.91 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
chr1_-_92951607 | 3.89 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
chr10_-_98480243 | 3.89 |
ENST00000339364.5
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1 |
chr14_-_106586656 | 3.81 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
chr14_-_107170409 | 3.76 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr19_-_7764960 | 3.74 |
ENST00000593418.1
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr11_+_60223312 | 3.71 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr1_+_206680879 | 3.69 |
ENST00000355294.4
ENST00000367117.3 |
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5 |
chr17_+_34430980 | 3.68 |
ENST00000250151.4
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr14_-_106805716 | 3.63 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
chr4_+_154387480 | 3.58 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
chr17_+_34640031 | 3.52 |
ENST00000339270.6
ENST00000482104.1 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
chr22_+_22697537 | 3.52 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
chr10_-_73848531 | 3.47 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr21_+_10862622 | 3.45 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr10_-_73848764 | 3.42 |
ENST00000317376.4
ENST00000412663.1 |
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr11_+_60223225 | 3.37 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr20_+_3776936 | 3.35 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
chr7_+_2687173 | 3.34 |
ENST00000403167.1
|
TTYH3
|
tweety family member 3 |
chr14_-_106725723 | 3.34 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr4_+_74718906 | 3.32 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
chr22_+_24823517 | 3.31 |
ENST00000496258.1
ENST00000337539.7 |
ADORA2A
|
adenosine A2a receptor |
chr11_-_441964 | 3.29 |
ENST00000332826.6
|
ANO9
|
anoctamin 9 |
chr3_-_71834318 | 3.25 |
ENST00000353065.3
|
PROK2
|
prokineticin 2 |
chr6_+_42883727 | 3.23 |
ENST00000304672.1
ENST00000441198.1 ENST00000446507.1 |
PTCRA
|
pre T-cell antigen receptor alpha |
chr1_-_169680745 | 3.22 |
ENST00000236147.4
|
SELL
|
selectin L |
chr19_+_7733929 | 3.19 |
ENST00000221515.2
|
RETN
|
resistin |
chr1_-_27961720 | 3.17 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr21_+_30503282 | 3.16 |
ENST00000399925.1
|
MAP3K7CL
|
MAP3K7 C-terminal like |
chr1_-_207096529 | 3.15 |
ENST00000525793.1
ENST00000529560.1 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr14_-_106471723 | 3.15 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
chr15_+_74833518 | 3.10 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr11_+_45944190 | 3.07 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
chr14_-_106967788 | 3.05 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr22_+_23247030 | 3.04 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr2_+_90121477 | 3.02 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr11_+_117857063 | 2.98 |
ENST00000227752.3
ENST00000541785.1 ENST00000545409.1 |
IL10RA
|
interleukin 10 receptor, alpha |
chr14_-_106539557 | 2.97 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
chr2_-_87017985 | 2.96 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
chr17_-_39191107 | 2.95 |
ENST00000344363.5
|
KRTAP1-3
|
keratin associated protein 1-3 |
chr16_-_11485922 | 2.94 |
ENST00000599216.1
|
CTD-3088G3.8
|
Protein LOC388210 |
chr2_+_218994002 | 2.92 |
ENST00000428565.1
|
CXCR2
|
chemokine (C-X-C motif) receptor 2 |
chr22_-_24181174 | 2.91 |
ENST00000318109.7
ENST00000406855.3 ENST00000404056.1 ENST00000476077.1 |
DERL3
|
derlin 3 |
chr16_-_89043605 | 2.90 |
ENST00000268679.4
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr7_+_12726623 | 2.90 |
ENST00000439721.1
|
ARL4A
|
ADP-ribosylation factor-like 4A |
chr16_-_31076332 | 2.90 |
ENST00000539836.3
ENST00000535577.1 ENST00000442862.2 |
ZNF668
|
zinc finger protein 668 |
chr2_-_158295915 | 2.89 |
ENST00000418920.1
|
CYTIP
|
cytohesin 1 interacting protein |
chr19_+_17638059 | 2.88 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
chr14_-_106668095 | 2.88 |
ENST00000390606.2
|
IGHV3-20
|
immunoglobulin heavy variable 3-20 |
chr14_-_107131560 | 2.87 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr6_+_31540056 | 2.86 |
ENST00000418386.2
|
LTA
|
lymphotoxin alpha |
chr14_-_107219365 | 2.86 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr7_+_50344289 | 2.85 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr2_-_87017948 | 2.85 |
ENST00000409781.1
|
CD8A
|
CD8a molecule |
chr11_+_1892102 | 2.83 |
ENST00000417766.1
|
LSP1
|
lymphocyte-specific protein 1 |
chr2_-_89292422 | 2.82 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr14_-_106114739 | 2.81 |
ENST00000460164.1
|
RP11-731F5.2
|
RP11-731F5.2 |
chr2_-_89619904 | 2.80 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr16_+_67679069 | 2.79 |
ENST00000545661.1
|
RLTPR
|
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
chr6_-_32731243 | 2.78 |
ENST00000427449.1
ENST00000411527.1 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr9_-_117150243 | 2.76 |
ENST00000374088.3
|
AKNA
|
AT-hook transcription factor |
chr21_+_30502806 | 2.74 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
chr7_+_142494038 | 2.73 |
ENST00000390412.1
|
TRBJ2-1
|
T cell receptor beta joining 2-1 |
chr9_-_35619539 | 2.72 |
ENST00000396757.1
|
CD72
|
CD72 molecule |
chrX_+_71354000 | 2.72 |
ENST00000510661.1
ENST00000535692.1 |
NHSL2
|
NHS-like 2 |
chr17_+_76165213 | 2.72 |
ENST00000590201.1
|
SYNGR2
|
synaptogyrin 2 |
chrX_+_123480194 | 2.72 |
ENST00000371139.4
|
SH2D1A
|
SH2 domain containing 1A |
chr15_-_22448819 | 2.70 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr6_-_31550192 | 2.69 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr2_-_89442621 | 2.69 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr4_+_102268904 | 2.66 |
ENST00000527564.1
ENST00000529296.1 |
AP001816.1
|
Uncharacterized protein |
chr22_+_22723969 | 2.64 |
ENST00000390295.2
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 (gene/pseudogene) |
chr16_-_89043488 | 2.63 |
ENST00000563640.1
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr1_+_207627575 | 2.63 |
ENST00000367058.3
ENST00000367057.3 ENST00000367059.3 |
CR2
|
complement component (3d/Epstein Barr virus) receptor 2 |
chr20_+_62369623 | 2.63 |
ENST00000467211.1
|
RP4-583P15.14
|
RP4-583P15.14 |
chr6_-_41122063 | 2.62 |
ENST00000426005.2
ENST00000437044.2 ENST00000373127.4 |
TREML1
|
triggering receptor expressed on myeloid cells-like 1 |
chr2_+_90198535 | 2.61 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr2_-_158345341 | 2.60 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
chr19_+_17865011 | 2.59 |
ENST00000596462.1
ENST00000596865.1 ENST00000598960.1 ENST00000539407.1 |
FCHO1
|
FCH domain only 1 |
chr16_+_32063311 | 2.58 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
chr2_+_69002052 | 2.58 |
ENST00000497079.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr14_-_106830057 | 2.57 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr6_-_32731299 | 2.57 |
ENST00000435145.2
ENST00000437316.2 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr1_+_28206150 | 2.56 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
chr19_-_48547294 | 2.56 |
ENST00000293255.2
|
CABP5
|
calcium binding protein 5 |
chr22_+_23089870 | 2.56 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr2_+_89923550 | 2.53 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr20_+_48884002 | 2.52 |
ENST00000425497.1
ENST00000445003.1 |
RP11-290F20.3
|
RP11-290F20.3 |
chr1_+_156119798 | 2.52 |
ENST00000355014.2
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr22_+_22385332 | 2.50 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr7_-_3083472 | 2.50 |
ENST00000356408.3
|
CARD11
|
caspase recruitment domain family, member 11 |
chr14_+_22386325 | 2.45 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
chr19_+_35634146 | 2.44 |
ENST00000586063.1
ENST00000270310.2 ENST00000588265.1 |
FXYD7
|
FXYD domain containing ion transport regulator 7 |
chr2_+_89184868 | 2.43 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr22_+_22516550 | 2.42 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr22_+_23010756 | 2.42 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr17_+_80193644 | 2.41 |
ENST00000582946.1
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3 |
chr16_+_81772633 | 2.40 |
ENST00000566191.1
ENST00000565272.1 ENST00000563954.1 ENST00000565054.1 |
RP11-960L18.1
PLCG2
|
RP11-960L18.1 phospholipase C, gamma 2 (phosphatidylinositol-specific) |
chr22_-_50970506 | 2.38 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
chr19_+_55085248 | 2.38 |
ENST00000391738.3
ENST00000251376.3 ENST00000391737.1 ENST00000396321.2 ENST00000418536.2 ENST00000448689.1 |
LILRA2
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr2_-_197036289 | 2.38 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
chr5_-_176326333 | 2.37 |
ENST00000292432.5
|
HK3
|
hexokinase 3 (white cell) |
chr14_+_21359558 | 2.37 |
ENST00000304639.3
|
RNASE3
|
ribonuclease, RNase A family, 3 |
chr7_-_3083573 | 2.36 |
ENST00000396946.4
|
CARD11
|
caspase recruitment domain family, member 11 |
chr17_-_46262541 | 2.36 |
ENST00000579336.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
chr16_-_88772670 | 2.36 |
ENST00000562544.1
|
RNF166
|
ring finger protein 166 |
chr22_+_23222886 | 2.35 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr4_-_165305086 | 2.34 |
ENST00000507270.1
ENST00000514618.1 ENST00000503008.1 |
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
chr16_-_88772761 | 2.32 |
ENST00000567844.1
ENST00000312838.4 |
RNF166
|
ring finger protein 166 |
chr3_+_122296443 | 2.32 |
ENST00000464300.2
|
PARP15
|
poly (ADP-ribose) polymerase family, member 15 |
chr12_+_6554021 | 2.31 |
ENST00000266557.3
|
CD27
|
CD27 molecule |
chr1_-_202129704 | 2.31 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr15_-_40600111 | 2.31 |
ENST00000543785.2
ENST00000260402.3 |
PLCB2
|
phospholipase C, beta 2 |
chr10_-_103347883 | 2.30 |
ENST00000339310.3
ENST00000370158.3 ENST00000299206.4 ENST00000456836.2 ENST00000413344.1 ENST00000429502.1 ENST00000430045.1 ENST00000370172.1 ENST00000436284.2 ENST00000370162.3 |
POLL
|
polymerase (DNA directed), lambda |
chr2_-_89247338 | 2.29 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr17_+_76164639 | 2.29 |
ENST00000225777.3
ENST00000585591.1 ENST00000589711.1 ENST00000588282.1 ENST00000589168.1 |
SYNGR2
|
synaptogyrin 2 |
chr14_-_106963409 | 2.29 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chrX_-_118827333 | 2.29 |
ENST00000360156.7
ENST00000354228.4 ENST00000489216.1 ENST00000354416.3 ENST00000394610.1 ENST00000343984.5 |
SEPT6
|
septin 6 |
chr13_+_108922228 | 2.28 |
ENST00000542136.1
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b |
chr3_-_27763803 | 2.27 |
ENST00000449599.1
|
EOMES
|
eomesodermin |
chr2_-_89340242 | 2.26 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr22_+_23264766 | 2.26 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr1_+_32716857 | 2.26 |
ENST00000482949.1
ENST00000495610.2 |
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr12_-_2027639 | 2.25 |
ENST00000586184.1
ENST00000587995.1 ENST00000585732.1 |
CACNA2D4
|
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
chr5_+_56111361 | 2.24 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr2_+_114163945 | 2.24 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr12_-_109027643 | 2.23 |
ENST00000388962.3
ENST00000550948.1 |
SELPLG
|
selectin P ligand |
chr9_+_129622904 | 2.23 |
ENST00000319119.4
|
ZBTB34
|
zinc finger and BTB domain containing 34 |
chr2_+_219745020 | 2.23 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chrX_+_123480375 | 2.21 |
ENST00000360027.4
|
SH2D1A
|
SH2 domain containing 1A |
chr17_+_39261584 | 2.21 |
ENST00000391415.1
|
KRTAP4-9
|
keratin associated protein 4-9 |
chr16_+_29674277 | 2.21 |
ENST00000395389.2
|
SPN
|
sialophorin |
chr12_-_53074182 | 2.21 |
ENST00000252244.3
|
KRT1
|
keratin 1 |
chr22_+_37678424 | 2.20 |
ENST00000248901.6
|
CYTH4
|
cytohesin 4 |
chrX_+_129305623 | 2.20 |
ENST00000257017.4
|
RAB33A
|
RAB33A, member RAS oncogene family |
chr16_+_57576584 | 2.19 |
ENST00000340339.4
|
GPR114
|
G protein-coupled receptor 114 |
chr19_+_42381173 | 2.19 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr3_-_71834207 | 2.18 |
ENST00000295619.3
|
PROK2
|
prokineticin 2 |
chr12_-_53601000 | 2.18 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
chr17_+_7239821 | 2.18 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr1_+_156119466 | 2.18 |
ENST00000414683.1
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr2_-_87018784 | 2.17 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
chr2_+_90139056 | 2.17 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr22_-_37608325 | 2.16 |
ENST00000328544.3
|
SSTR3
|
somatostatin receptor 3 |
chr1_+_32716840 | 2.15 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr7_+_128784712 | 2.15 |
ENST00000289407.4
|
TSPAN33
|
tetraspanin 33 |
chr17_+_43299241 | 2.14 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
chr19_+_42381337 | 2.14 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr11_+_118215036 | 2.13 |
ENST00000392883.2
ENST00000532917.1 |
CD3G
|
CD3g molecule, gamma (CD3-TCR complex) |
chr22_+_23134974 | 2.13 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr16_+_12058961 | 2.13 |
ENST00000053243.1
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17 |
chr17_+_7239904 | 2.13 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr4_+_40198527 | 2.12 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
chr20_+_57766075 | 2.12 |
ENST00000371030.2
|
ZNF831
|
zinc finger protein 831 |
chr14_+_22554680 | 2.12 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 21.4 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
3.1 | 15.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.7 | 10.1 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
1.6 | 8.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.4 | 4.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
1.4 | 4.1 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
1.3 | 3.9 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
1.2 | 8.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.2 | 1.2 | GO:0019724 | B cell mediated immunity(GO:0019724) |
1.1 | 3.4 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.1 | 6.6 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
1.1 | 3.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) negative regulation of chloride transport(GO:2001226) |
1.1 | 4.3 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
1.1 | 3.2 | GO:2000870 | positive regulation of female gonad development(GO:2000196) regulation of progesterone secretion(GO:2000870) |
0.9 | 76.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.9 | 3.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.9 | 4.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.8 | 3.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.8 | 2.4 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.8 | 3.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.7 | 10.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.7 | 3.6 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.7 | 0.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.7 | 2.1 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.7 | 2.7 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
0.7 | 4.0 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.6 | 4.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 3.2 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 0.6 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.6 | 76.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.6 | 0.6 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
0.6 | 3.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.6 | 0.6 | GO:0002605 | negative regulation of dendritic cell antigen processing and presentation(GO:0002605) |
0.6 | 1.8 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.6 | 3.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.6 | 1.8 | GO:1904346 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.6 | 2.4 | GO:0002290 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.6 | 1.7 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.6 | 1.1 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.5 | 3.7 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.5 | 3.7 | GO:0051510 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.5 | 1.6 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.5 | 1.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 2.0 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.5 | 7.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 0.5 | GO:1903036 | positive regulation of response to wounding(GO:1903036) |
0.5 | 8.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.5 | 1.5 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.5 | 1.5 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.5 | 1.4 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 3.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 93.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 8.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.4 | 0.4 | GO:0072608 | interleukin-10 secretion(GO:0072608) |
0.4 | 2.6 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.4 | 2.2 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.4 | 1.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.4 | 4.2 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 0.4 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.4 | 0.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.4 | 2.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.4 | 10.5 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.4 | 1.6 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 1.2 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.4 | 1.2 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.4 | 1.1 | GO:1903980 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) positive regulation of microglial cell activation(GO:1903980) |
0.4 | 1.9 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.4 | 0.8 | GO:0035106 | operant conditioning(GO:0035106) |
0.4 | 1.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) leukocyte migration involved in immune response(GO:0002522) |
0.4 | 3.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.4 | 1.1 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.4 | 1.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.4 | 1.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.4 | 0.4 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.4 | 2.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 2.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 1.1 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.3 | 2.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 1.0 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.3 | 0.7 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.7 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 1.3 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.3 | 1.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 2.0 | GO:0061056 | sclerotome development(GO:0061056) |
0.3 | 1.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.3 | 1.3 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.3 | 2.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 1.0 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.3 | 1.0 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.3 | 1.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 1.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.3 | 0.3 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.3 | 3.2 | GO:0050867 | positive regulation of cell activation(GO:0050867) |
0.3 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.3 | 3.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 1.2 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 0.6 | GO:0002883 | regulation of hypersensitivity(GO:0002883) |
0.3 | 1.2 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.3 | 0.9 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.3 | 4.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 4.3 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 0.9 | GO:0032639 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.3 | 0.9 | GO:1900369 | transcription, RNA-templated(GO:0001172) negative regulation of RNA interference(GO:1900369) |
0.3 | 0.9 | GO:0045925 | positive regulation of female receptivity(GO:0045925) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 1.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.3 | 0.8 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.3 | 1.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 1.7 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 1.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.3 | 0.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 2.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 1.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 1.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.3 | 1.3 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.3 | 3.2 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.3 | 1.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.3 | 1.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.3 | 1.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.3 | 1.6 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.3 | 1.6 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 1.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.3 | 0.8 | GO:0021586 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.3 | 1.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.5 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.3 | 2.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 0.5 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.3 | 0.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 2.0 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 1.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 0.7 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.2 | 4.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 7.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 1.7 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.2 | 1.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 3.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 0.7 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.2 | 1.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 5.0 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.2 | 1.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 1.4 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.2 | 1.0 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.2 | 3.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.2 | 4.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.7 | GO:0044209 | AMP salvage(GO:0044209) |
0.2 | 0.7 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.2 | 0.7 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.2 | 0.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.2 | 4.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.2 | 1.4 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.2 | 0.7 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 1.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 2.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 2.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 0.2 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.2 | 2.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.2 | 0.7 | GO:0051714 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
0.2 | 1.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.2 | 1.1 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.2 | 0.6 | GO:0035623 | renal glucose absorption(GO:0035623) |
0.2 | 0.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 0.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 13.5 | GO:0042100 | B cell proliferation(GO:0042100) |
0.2 | 0.9 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 1.9 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 2.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.2 | 5.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.2 | 2.5 | GO:0048003 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 6.5 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.2 | 1.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 1.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 15.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.2 | 1.0 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.2 | 2.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 2.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 4.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 1.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.2 | 1.7 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.2 | 3.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.2 | 0.6 | GO:0030969 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.2 | 3.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 1.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.6 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 0.6 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.2 | 1.8 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.2 | 3.9 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.2 | 2.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.2 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 1.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 2.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.4 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.2 | 1.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 0.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.5 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.2 | 0.5 | GO:0098972 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.2 | 1.1 | GO:0033563 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) dorsal/ventral axon guidance(GO:0033563) |
0.2 | 2.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.9 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 0.9 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.2 | 0.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.2 | 2.6 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.2 | 0.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.2 | 0.9 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.5 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.2 | 1.0 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.2 | 3.2 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.2 | 3.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.5 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.2 | 0.8 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.2 | 4.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 5.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 0.2 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.2 | 0.7 | GO:0061324 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.2 | 5.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 3.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.2 | 7.8 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.2 | 1.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 0.6 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 2.9 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.5 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 1.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 0.6 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.2 | 0.6 | GO:0032571 | response to vitamin K(GO:0032571) |
0.2 | 0.5 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.2 | 0.8 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.2 | 0.8 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.2 | 0.5 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 2.2 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.4 | GO:1900737 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.1 | 3.7 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.4 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.1 | 1.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 1.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 2.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 1.0 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 1.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.3 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.1 | 0.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.7 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.1 | 1.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.1 | 0.4 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
0.1 | 1.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 1.1 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.9 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.1 | 1.2 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 1.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.8 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 3.0 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 0.5 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.1 | 1.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.4 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
0.1 | 0.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 1.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 2.8 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.9 | GO:0090197 | regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 3.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.7 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 1.1 | GO:2000406 | positive regulation of lymphocyte migration(GO:2000403) positive regulation of T cell migration(GO:2000406) |
0.1 | 0.6 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 1.0 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.1 | GO:0060632 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) regulation of microtubule-based movement(GO:0060632) |
0.1 | 1.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.8 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 4.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 1.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 1.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.2 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.1 | 0.5 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.1 | 1.7 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.1 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 1.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 1.9 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.5 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.5 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.8 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 0.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:0042098 | T cell proliferation(GO:0042098) |
0.1 | 0.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.4 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.4 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 0.1 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.1 | 0.9 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.5 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 3.6 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 1.7 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.5 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.1 | 0.5 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 1.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.7 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 2.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.3 | GO:0021940 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 5.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 1.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 21.5 | GO:0002250 | adaptive immune response(GO:0002250) |
0.1 | 0.8 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.1 | 1.1 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.1 | 1.0 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.1 | 1.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.1 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 4.2 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.1 | 0.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 2.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 2.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.1 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.1 | 0.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.1 | GO:0060701 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.1 | 6.7 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.6 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
0.1 | 0.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
0.1 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 1.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.2 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.1 | 1.3 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 1.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.2 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.1 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.5 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.1 | 0.3 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.1 | 1.6 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.5 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 | 3.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 1.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.2 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 1.8 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 1.3 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
0.1 | 1.7 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.1 | 0.4 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 1.0 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 1.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.8 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 1.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 1.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 4.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.5 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.1 | 0.3 | GO:0070846 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.1 | 2.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.3 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.1 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 1.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 1.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 1.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.4 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 0.4 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.5 | GO:0015677 | copper ion import(GO:0015677) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.4 | GO:0061738 | vacuolar transmembrane transport(GO:0034486) late endosomal microautophagy(GO:0061738) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
0.1 | 4.6 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.1 | 1.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.1 | GO:0051958 | methotrexate transport(GO:0051958) |
0.1 | 1.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 0.7 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.1 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.1 | 0.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 1.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) negative regulation of gap junction assembly(GO:1903597) |
0.1 | 0.7 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.1 | 1.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 2.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.4 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.5 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 2.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.5 | GO:0006260 | DNA replication(GO:0006260) |
0.1 | 0.7 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 0.9 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.2 | GO:0002384 | hepatic immune response(GO:0002384) |
0.1 | 0.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 1.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.5 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 1.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.2 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 1.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.5 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.1 | 2.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 1.8 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 0.3 | GO:0002551 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 6.4 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.1 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
0.1 | 0.3 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 1.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.4 | GO:0045589 | regulatory T cell differentiation(GO:0045066) regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.2 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 0.2 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.2 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 2.3 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 | 1.0 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.4 | GO:0046373 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.1 | 3.7 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.2 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.8 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 0.9 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 2.5 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.1 | 1.6 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 1.0 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.2 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.1 | 0.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 1.3 | GO:0000732 | strand displacement(GO:0000732) |
0.1 | 0.4 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.3 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.1 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.0 | 0.3 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.2 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
0.0 | 0.3 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 2.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 1.6 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 1.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.0 | 1.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.0 | 0.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.0 | 0.8 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.0 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.4 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.0 | 0.4 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 1.1 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 1.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.2 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.0 | 0.2 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.0 | 0.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 2.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.0 | 1.5 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.1 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.0 | 0.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 2.2 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.9 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 5.5 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 23.6 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.2 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 1.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.0 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 3.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 2.6 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.7 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.8 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.2 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.3 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0021747 | cochlear nucleus development(GO:0021747) neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.1 | GO:0070904 | L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
0.0 | 1.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.3 | GO:0043385 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.3 | GO:0016571 | histone methylation(GO:0016571) |
0.0 | 0.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.5 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.1 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 1.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 1.5 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 1.0 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 1.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.1 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.0 | 0.2 | GO:1901355 | cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
0.0 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 3.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.1 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 0.3 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.0 | 0.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.0 | 0.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.0 | 3.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.2 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 2.6 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.4 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.0 | 0.1 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.0 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.0 | 0.5 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 2.0 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.3 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 1.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.2 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 3.4 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 2.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 1.1 | GO:0044784 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.0 | 0.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 1.5 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.0 | 0.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.1 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.3 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.0 | 0.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.2 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 0.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.2 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) nuclear migration along microfilament(GO:0031022) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.1 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 1.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 1.2 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.4 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.0 | 0.1 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.0 | 0.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.5 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.1 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 2.1 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.3 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.3 | GO:0001945 | lymph vessel development(GO:0001945) |
0.0 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.0 | 1.6 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.1 | GO:0071362 | cellular response to ether(GO:0071362) |
0.0 | 0.2 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.8 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 | 0.1 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.0 | 0.1 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.0 | 0.1 | GO:0000423 | macromitophagy(GO:0000423) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.0 | GO:0006433 | glutamyl-tRNA aminoacylation(GO:0006424) prolyl-tRNA aminoacylation(GO:0006433) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.0 | 0.0 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.1 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.0 | 0.0 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.0 | 0.0 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.0 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
1.4 | 74.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
1.1 | 7.9 | GO:0019814 | immunoglobulin complex(GO:0019814) |
1.0 | 3.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 7.1 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.9 | 4.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.8 | 4.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 25.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.7 | 2.1 | GO:0097679 | other organism cytoplasm(GO:0097679) |
0.6 | 3.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.6 | 2.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.5 | 2.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.5 | 2.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.4 | 2.2 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.4 | 1.3 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.4 | 7.2 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 2.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.4 | 1.2 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.4 | 1.6 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.4 | 6.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 4.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.4 | 4.0 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 3.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.3 | 7.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 13.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 8.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.9 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.3 | 2.8 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 29.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.3 | 1.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 1.5 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.3 | 0.8 | GO:0036398 | TCR signalosome(GO:0036398) |
0.2 | 1.0 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.2 | 1.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 4.3 | GO:0032059 | bleb(GO:0032059) |
0.2 | 2.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 8.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.7 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.2 | 1.3 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.2 | 9.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 1.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 0.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 0.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.2 | 0.5 | GO:0075341 | host cell PML body(GO:0075341) |
0.2 | 1.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 4.4 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 0.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.2 | 1.5 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 0.5 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 2.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.4 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.1 | 1.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.4 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 12.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.1 | 0.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 11.5 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.7 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.1 | 1.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 1.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 2.6 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.6 | GO:0001652 | granular component(GO:0001652) |
0.1 | 2.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.5 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.1 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 1.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.8 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 3.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 1.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 1.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 1.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 1.9 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 8.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 9.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 3.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.8 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 11.5 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 1.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.9 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 2.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 17.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.9 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 7.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 2.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.8 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.4 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 2.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 1.0 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.9 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 15.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 0.3 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.1 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
0.1 | 0.2 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.1 | 1.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 2.2 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 1.2 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.2 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 0.6 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.6 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 1.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 6.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.1 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
0.1 | 0.5 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 1.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 7.4 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 9.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 1.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 1.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 4.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.6 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 2.1 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 2.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 1.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.5 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 2.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.0 | 1.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.2 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.0 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 9.4 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 2.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 3.4 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
0.0 | 0.2 | GO:0070701 | mucus layer(GO:0070701) |
0.0 | 3.9 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 1.4 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 3.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.0 | 0.1 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.0 | 9.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 2.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 1.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.5 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 2.6 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 1.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 3.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.6 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 1.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 2.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.2 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.0 | 40.0 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 3.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.4 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.0 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 1.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.0 | 1.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 1.4 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.0 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 1.8 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 0.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 1.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.6 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 2.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 1.3 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 8.2 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.0 | 0.2 | GO:0035371 | microtubule plus-end(GO:0035371) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 21.4 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
5.1 | 15.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
1.7 | 10.1 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
1.6 | 8.0 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.2 | 8.7 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.2 | 78.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.9 | 3.6 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.9 | 5.3 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.9 | 10.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.7 | 11.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 150.0 | GO:0003823 | antigen binding(GO:0003823) |
0.7 | 4.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 2.0 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.6 | 7.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.6 | 3.9 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.6 | 1.9 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
0.6 | 1.8 | GO:0001861 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
0.6 | 1.8 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.6 | 5.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.5 | 1.6 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.5 | 2.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 6.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.5 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.4 | 5.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.4 | 1.3 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.4 | 1.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 4.3 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 1.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.4 | 2.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 2.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 3.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 4.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 1.1 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.4 | 1.1 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
0.4 | 1.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.4 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 1.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.4 | 1.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.3 | 3.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 2.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.3 | 1.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.3 | 1.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 6.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 2.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.3 | 3.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.3 | 1.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 1.5 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.3 | 1.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 3.7 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.3 | 1.5 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
0.3 | 0.9 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.3 | 0.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.3 | 7.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 1.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 0.3 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.3 | 1.1 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.3 | 2.2 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.3 | 1.1 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.3 | 12.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 2.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 0.8 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.3 | 0.8 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.2 | 0.7 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.2 | 2.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.0 | GO:1903135 | cupric ion binding(GO:1903135) |
0.2 | 1.7 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.2 | 1.0 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.2 | 1.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 1.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.2 | 3.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 2.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 8.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 1.8 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 6.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 2.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 1.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.2 | 1.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.2 | 1.0 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.2 | 1.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 6.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 3.9 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 8.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 3.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 1.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 3.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 1.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 0.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 10.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 10.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 2.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.2 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 7.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 1.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 6.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 1.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.2 | 2.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.5 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.2 | 3.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 1.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.2 | 0.2 | GO:0030546 | receptor activator activity(GO:0030546) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 5.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 0.5 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.2 | 1.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 0.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.2 | 0.7 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.2 | 0.6 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.2 | 1.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.2 | 4.6 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 0.6 | GO:0017129 | triglyceride binding(GO:0017129) |
0.2 | 0.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.2 | 5.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 6.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 20.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.5 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 3.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 4.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 3.2 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 2.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.4 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.1 | 1.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 0.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.1 | 1.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 0.4 | GO:0030395 | lactose binding(GO:0030395) |
0.1 | 0.4 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
0.1 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 2.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 5.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.1 | 0.4 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 1.3 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.1 | 1.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 2.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 5.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 2.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 1.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 2.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.5 | GO:0004335 | galactokinase activity(GO:0004335) |
0.1 | 0.5 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.1 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.3 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.1 | 0.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.5 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 1.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.1 | 0.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.5 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.1 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 2.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.4 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 0.3 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 2.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 3.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 2.3 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 1.0 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 8.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.1 | 0.9 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.3 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.1 | 0.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.8 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.1 | 0.2 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.1 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 2.0 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.3 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 4.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 1.0 | GO:0015165 | nucleotide-sugar transmembrane transporter activity(GO:0005338) pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 9.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.1 | 1.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 1.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.3 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 4.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 3.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 1.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) extracellular ATP-gated cation channel activity(GO:0004931) nucleotide receptor activity(GO:0016502) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.1 | 3.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 2.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 1.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
0.1 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 4.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 0.2 | GO:0098782 | temperature-gated cation channel activity(GO:0097604) mechanically-gated potassium channel activity(GO:0098782) |
0.1 | 0.2 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.1 | 0.4 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 3.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.1 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 1.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 0.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 2.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.8 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.3 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.1 | 3.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 2.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.6 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 1.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.2 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.1 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.1 | 1.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 3.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 2.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 1.5 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 0.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 1.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 2.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 6.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 1.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
0.1 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.1 | 1.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.4 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 0.3 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 26.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.9 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 4.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 1.1 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 1.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 1.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 1.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.2 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.0 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.3 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 1.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.4 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.4 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 9.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 1.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.9 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 1.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.3 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.4 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.1 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 2.0 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 1.0 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 1.0 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.0 | 0.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 9.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.4 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 0.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 2.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 1.8 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 1.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.7 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 2.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.3 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.0 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.5 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.0 | 0.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.0 | 0.1 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.0 | 0.1 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
0.0 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.0 | 0.5 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 2.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.0 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.0 | 0.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.1 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.8 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 27.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 7.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 44.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 21.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 27.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 1.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 9.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 9.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 12.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 17.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 2.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 5.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 8.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 2.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 4.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 4.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 6.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 8.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 7.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 5.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 4.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 3.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 2.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 2.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 5.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 2.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 3.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 3.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 4.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 8.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 1.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.8 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 2.9 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 9.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.9 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 5.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 4.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 2.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 2.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 2.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 8.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 3.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 9.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.2 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 21.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.4 | 11.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 4.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 9.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.4 | 5.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 2.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 25.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 22.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 0.6 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.3 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.3 | 30.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 4.5 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 7.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 7.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 4.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 6.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 6.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 20.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 3.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 6.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 5.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 6.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 2.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 2.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 5.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.3 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.5 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 5.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 4.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 3.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 1.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 3.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 3.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 12.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 6.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 2.3 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 6.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 4.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 16.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 3.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 3.7 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 2.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 2.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.4 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 8.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 1.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 1.8 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.0 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 1.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.4 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 2.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 1.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.6 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.7 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 3.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 3.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 2.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 2.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 2.0 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 2.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 2.1 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 1.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.8 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.8 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |